Month: April 2024
Duggan, Tampa General Hospital’s EVP, chief physician executive and chief medical officer, is recognized by Tampa Bay Business Journal as one of the region’s most influential businesswomen. TAMPA, Fla., April 2, 2024 /PRNewswire/ — Dr. Peggy Duggan, executive vice president, chief…
Duggan, Tampa General Hospital’s EVP, chief physician executive and chief medical officer, is recognized by Tampa Bay Business Journal as one of the region’s most influential businesswomen. TAMPA, Fla., April 2, 2024 /PRNewswire/ — Dr. Peggy Duggan, executive vice president, chief…
CALGARY, AB, April 2, 2024 /PRNewswire/ – Boardwalk Real Estate Investment Trust – TSX: BEI.UN Boardwalk REIT (“Boardwalk”, “the Trust”, “We”) is providing a brief operational update highlighting continued strength in occupancy and steadily increasing occupied rents heading into the…
CALGARY, AB, April 2, 2024 /PRNewswire/ – Boardwalk Real Estate Investment Trust – TSX: BEI.UN Boardwalk REIT (“Boardwalk”, “the Trust”, “We”) is providing a brief operational update highlighting continued strength in occupancy and steadily increasing occupied rents heading into the…
TaxBit verwelkomt Dr. Max Bernt, de vooraanstaande Europese expert, als Managing Director van Europa. NEW YORK, 2 april 2024 /PRNewswire/ — TaxBit, de marktleider op het gebied van belasting- en boekhoudoplossingen voor digitale activa, kondigt zijn strategische uitbreiding naar Europa…
TaxBit verwelkomt Dr. Max Bernt, de vooraanstaande Europese expert, als Managing Director van Europa. NEW YORK, 2 april 2024 /PRNewswire/ — TaxBit, de marktleider op het gebied van belasting- en boekhoudoplossingen voor digitale activa, kondigt zijn strategische uitbreiding naar Europa…
The retinitis pigmentosa market is propelled forward by advancements in gene therapy and innovative treatment modalities, offering promising prospects for slowing down the progression of this degenerative eye disease. Additionally, increasing research investments, growing awareness, and…
The retinitis pigmentosa market is propelled forward by advancements in gene therapy and innovative treatment modalities, offering promising prospects for slowing down the progression of this degenerative eye disease. Additionally, increasing research investments, growing awareness, and…
MILWAUKEE, April 2, 2024 /PRNewswire/ — MGIC Investment Corporation (NYSE: MTG) has announced plans to release its first quarter 2024 financial results after the market closes on Wednesday, May 1, 2024. A conference call/webcast has been scheduled for 10:00 a.m. Eastern Time on Thursday,…
